Fiduciary Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11M | Sell |
31,271
-224
| -0.7% | -$79.9K | 0.94% | 27 |
|
|
2025
Q4 | $10.3M | Sell |
31,495
-231
| -0.7% | -$73.3K | 0.87% | 30 |
|
|
2025
Q3 | $8.95M | Buy |
31,726
+204
| +0.6% | +$59.2K | 0.79% | 34 |
|
|
2025
Q2 | $8.8M | Sell |
31,522
-154
| -0.5% | -$43.6K | 0.83% | 34 |
|
|
2025
Q1 | $9.87M | Buy |
31,676
+26
| +0.1% | +$7.68K | 0.99% | 28 |
|
|
2024
Q4 | $8.25M | Sell |
31,650
-325
| -1% | -$96.4K | 0.83% | 31 |
|
|
2024
Q3 | $10.3M | Sell |
31,975
-410
| -1% | -$134K | 1.04% | 24 |
|
|
2024
Q2 | $10.1M | Sell |
32,385
-548
| -2% | -$161K | 1.09% | 24 |
|
|
2024
Q1 | $9.36M | Sell |
32,933
-448
| -1% | -$131K | 1.02% | 25 |
|
|
2023
Q4 | $9.61M | Sell |
33,381
-2,828
| -8% | -$771K | 1.13% | 23 |
|
|
2023
Q3 | $9.73M | Sell |
36,209
-190
| -0.5% | -$47.4K | 1.24% | 21 |
|
|
2023
Q2 | $8.08M | Buy |
36,399
+6
| +0% | +$1.39K | 0.99% | 30 |
|
|
2023
Q1 | $8.8M | Buy |
36,393
+157
| +0.4% | +$38.5K | 1.14% | 27 |
|
|
2022
Q4 | $9.52M | Sell |
36,236
-520
| -1% | -$139K | 1.27% | 21 |
|
|
2022
Q3 | $10.7M | Buy |
36,756
+442
| +1% | +$107K | 1.39% | 21 |
|
|
2022
Q2 | $9.02M | Sell |
36,314
-342
| -0.9% | -$83.8K | 1.13% | 27 |
|
|
2022
Q1 | $8.82M | Buy |
36,656
+933
| +3% | +$214K | 1.16% | 26 |
|
|
2021
Q4 | $8.04M | Sell |
35,723
-66
| -0.2% | -$13.9K | 0.89% | 35 |
|
|
2021
Q3 | $7.47M | Buy |
35,789
+2,567
| +8% | +$591K | 0.85% | 39 |
|
|
2021
Q2 | $7.58M | Buy |
33,222
+821
| +3% | +$202K | 0.88% | 36 |
|
|
2021
Q1 | $7.76M | Buy |
32,401
+1,612
| +5% | +$385K | 0.94% | 35 |
|
|
2020
Q4 | $7.24M | Buy |
30,789
+692
| +2% | +$160K | 0.95% | 34 |
|
|
2020
Q3 | $7.65M | Buy |
30,097
+11
| +0% | +$2.73K | 1.16% | 27 |
|
|
2020
Q2 | $7.1M | Buy |
30,086
+561
| +2% | +$128K | 1.18% | 26 |
|
|
2020
Q1 | $5.99M | Buy |
29,525
+831
| +3% | +$182K | 1.17% | 26 |
|
|
2019
Q4 | $6.92M | Buy |
28,694
+266
| +0.9% | +$58.6K | 1.1% | 30 |
|
|
2019
Q3 | $5.5M | Buy |
28,428
+2,147
| +8% | +$412K | 0.96% | 38 |
|
|
2019
Q2 | $4.84M | Buy |
26,281
+3,519
| +15% | +$630K | 0.87% | 39 |
|
|
2019
Q1 | $4.32M | Buy |
22,762
+344
| +2% | +$65.7K | 0.8% | 41 |
|
|
2018
Q4 | $4.36M | Buy |
22,418
+1,537
| +7% | +$300K | 0.9% | 36 |
|
|
2018
Q3 | $4.33M | Buy |
20,881
+763
| +4% | +$150K | 0.85% | 40 |
|
|
2018
Q2 | $3.71M | Buy |
20,118
+303
| +2% | +$53.6K | 0.79% | 44 |
|
|
2018
Q1 | $3.38M | Buy |
19,815
+1,300
| +7% | +$239K | 0.73% | 44 |
|
|
2017
Q4 | $3.22M | Buy |
18,515
+1,666
| +10% | +$295K | 0.69% | 45 |
|
|
2017
Q3 | $3.14M | Buy |
16,849
+2,412
| +17% | +$427K | 0.71% | 46 |
|
|
2017
Q2 | $2.49M | Sell |
14,437
-432
| -3% | -$70.3K | 0.57% | 53 |
|
|
2017
Q1 | $2.44M | Buy |
14,869
+2,922
| +24% | +$486K | 0.58% | 53 |
|
|
2016
Q4 | $1.75M | Buy |
11,947
+482
| +4% | +$72.5K | 0.45% | 68 |
|
|
2016
Q3 | $1.91M | Buy |
11,465
+528
| +5% | +$89.3K | 0.52% | 65 |
|
|
2016
Q2 | $1.66M | Buy |
10,937
+320
| +3% | +$49.8K | 0.46% | 64 |
|
|
2016
Q1 | $1.59M | Sell |
10,617
-124
| -1% | -$18.4K | 0.46% | 62 |
|
|
2015
Q4 | $1.74M | Buy |
10,741
+3,813
| +55% | +$599K | 0.52% | 58 |
|
|
2015
Q3 | $958K | Buy |
6,928
+1,497
| +28% | +$236K | 0.32% | 91 |
|
|
2015
Q2 | $834K | Buy |
+5,431
| New | +$870K | 0.26% | 107 |
|
Other funds holding AMGN
VCM
VPM
Fiduciary Group's AMGN Position: Q1 2026 in Review
Fiduciary Group reduced its Amgen (AMGN) stake by 0.71% in Q1 2026, selling an estimated $79.9K and leaving 31,271 shares worth $11M. The position accounts for 0.94% of the portfolio, ranked #27.
Fiduciary Group first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Fiduciary Group held 31,271 shares of Amgen worth $11M as of Q1 2026.
- Fiduciary Group sold 224 Amgen shares in Q1 2026, an estimated $79.9K.
- Amgen made up 0.94% of Fiduciary Group's portfolio in Q1 2026, its #27 holding.
- Fiduciary Group first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.